Mathias Schmid

3.7k citations
79 papers · 3.1k · 1 hit paper · h-index 25

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Iron Metabolism and Disorders
  • Genetics top 2%
    • Hemoglobinopathies and Related Disorders

Papers in

    • Acute Myeloid Leukemia Research 17
    • Iron Metabolism and Disorders 11
    • Multiple Myeloma Research and Treatments 3
    • Hemoglobinopathies and Related Disorders 10
    • Chronic Lymphocytic Leukemia Research 8

Mathias Schmid

78 papers receiving 3k citations

Mathias Schmid's Hit Papers

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival 2011 · 776 citations
7760+5+10Years since publication250500750

Peers

Mathias Schmid
Comparison fields: 5 of 79
  • Hematology 883
  • Genetics 387
  • Public Health, Environmental and Occupational Health 703
  • Oncology 368
  • Radiology, Nuclear Medicine and Imaging 223
Replace Leonard T. Heffner with:
Leonard T. Heffner United States
Mehrdad Abedi United States
Thorsten Raff Germany
ECKHARD THIEL Germany
Yang O. Huh United States
Todd M. Cooper United States
Luciana Vinti Italy
Udo Holtick Germany
Francine Garnache‐Ottou France
Hélène Antoine Poirel Belgium
Mathias Schmid relative to Leonard T. Heffner United States Leonard T. Heffner's profile →
Citations per field
00.5×1.5×
Leonard T. Heffner · 1×
Citations per year

Countries citing papers authored by Mathias Schmid

Since Specialization
Citations

This map shows the geographic impact of Mathias Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Schmid more than expected).

Fields of papers citing papers by Mathias Schmid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Schmid. The network helps show where Mathias Schmid may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathias Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathias Schmid Line = papers co-authored together Mathias Schmid links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Hit paper breakdown →
2011776
2 2011205
3 2005203
4 2010153
5 2012148
6 199993
7 199891
8 199286
9 200582
10 200480
11 201075
12 199765
13 201054
14
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
200553
15 201050
16 200046
17 202335
18 200931
19 201331
20 200030

About Mathias Schmid

Mathias Schmid is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Emergency Medicine, having authored 79 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (17 papers), Iron Metabolism and Disorders (11 papers), Hemoglobinopathies and Related Disorders (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (3 papers) and HIV-related health complications and treatments (3 papers). The work is most often cited by research in Hematology (883 citations), Genetics (387 citations), Public Health, Environmental and Occupational Health (703 citations), Oncology (368 citations) and Radiology, Nuclear Medicine and Imaging (223 citations). Mathias Schmid has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Hartmut Doehner, Franz Porzsolt, Ulrich Germing, Andrea Kuendgen, Dennis Anthony Carson, Agnès Guerci‐Bresler, Matteo Giovanni Della Porta, Norbert Gattermann, Arnold Ganser and Bernard Roubert. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, British Journal of Haematology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact